Guardant Health (GH) Current Deferred Revenue (2017 - 2026)

Guardant Health (GH) has 10 years of Current Deferred Revenue data on file, last reported at $56.7 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 28.86% year-over-year to $56.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.7 million (up 28.86% YoY) and the FY2025 annual result came in at $50.8 million, up 22.0% from the prior year.
• Current Deferred Revenue grew to $56.7 million in Q1 2026 per GH's latest filing, from $50.8 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $60.7 million in Q2 2025, with the low at $10.6 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $31.2 million, with a median of $27.8 million recorded in 2024.
• Year-over-year, Current Deferred Revenue jumped 110.47% in 2022 and retreated 12.72% in 2023.
• Guardant Health's Current Deferred Revenue stood at $17.4 million in 2022, then jumped by 31.59% to $22.9 million in 2023, then soared by 81.66% to $41.6 million in 2024, then climbed by 22.0% to $50.8 million in 2025, then rose by 11.72% to $56.7 million in 2026.
• Business Quant data shows GH's Current Deferred Revenue at $56.7 million in Q1 2026, $50.8 million in Q4 2025, and $46.9 million in Q3 2025.